Authorities “debating strategy” on study result of weakening vaccine efficacy of mutant virus

Authorities “debating strategy” on study result of weakening vaccine efficacy of mutant virus

Revision 2021.03.01 17:03Input 2021.03.01 17:00


Authorities say the results of a study on weakening the efficacy of a mutant virus vaccine
[이미지출처=연합뉴스]

[아시아경제 구은모 기자] The quarantine authorities noted that they are discussing strategies while watching the situation about the findings of a study that the corona 19 mutant virus, which is spreading worldwide recently, lowers the efficacy of the vaccine.

In a regular online briefing on the 1st, Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters, said, “Currently, research and analysis on the efficacy and effectiveness of each vaccine against each mutant virus are ongoing.” “It is judged that the mutation site can affect the vaccine efficacy.”

“There are some papers that reported that the NovaVax vaccine has a relatively high effect on mutations from South Africa, about 60%, and that the Janssen vaccine is also effective at about 57%.” It was reported to be lower than that,” he explained.

“Modena and Pfizer vaccines are also reported to have poor neutralizing ability (the ability to neutralize the virus), so the quarantine authorities are also paying close attention.” Said.

According to the quarantine authorities, a total of 156 mutant virus infections were confirmed in Korea until this day. Among them, there were 133 mutations from the UK, 17 from South Africa, and 6 from Brazil.

Reporter Eun-mo Koo [email protected]

.Source